Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | RAD52 | P43351 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14354685 | 0.81 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL5590336 | 0.79 | ALOX5 (0.44) | HTTMAPK1NPSR1NPC1HPGD | |
| SCHEMBL11483316 | 0.77 | HTT (0.42) | SMN1; SMN2TDP1HTTMAPTMAPK1 | |
| SCHEMBL5589928 | 0.75 | ALOX5 (0.43) | HTTMAPK1NPSR1NPC1HPGD | |
| SCHEMBL27442462 | 0.72 | HTT (0.57) | GAAL3MBTL1SMN1; SMN2TDP1GLA | |
| SCHEMBL25328760 | 0.71 | ESR1 (0.40) | MAPTHPGDESR1ALDH1A1TYR | |
| SCHEMBL10936704 | 0.71 | ALOX5 (0.43) | HTR2A | |
| SCHEMBL23070366 | 0.71 | PSEN1 (0.46) | CYP1A2CYP2C9CYP2C19SLC2A1GAA | |
| SCHEMBL8439788 | 0.70 | HTR2A (0.45) | HTR2A | |
| SCHEMBL19313676 | 0.70 | HTR2A (0.41) | L3MBTL1SMN1; SMN2HTTMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230414512-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2023-12-28 | — | — | US | disclosed |
| EP-4218718-A2 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | Laboratory Skin Care, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-2427178-B1 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | LABORATORY SKIN CARE INC (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20210220276-A1 | Methods of Treating Skin | LABORATORY SKIN CARE, INC. | 2021-07-22 | — | — | US | disclosed |
| EP-3771335-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| EP-3771336-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| US-20200138718-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2020-05-07 | — | — | US | disclosed |
| US-10350168-B2 | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | LABORATORY SKIN CARE, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20170340566-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2017-11-30 | — | — | US | disclosed |
| US-9707177-B2 | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | LABORATORY SKIN CARE, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20030114562-A1 | Tinting composition and method of use | PENNZOIL-QUAKER STATE COMPANY | 2003-06-19 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2003002674-A1 | COATING COMPOSITION | PENNZOIL-QUAKER STATE COMPANY (US) | 2003-01-09 | — | — | WO | disclosed |
| US-20030004241-A1 | Use of copolymers based on acrylamidoalkylsulfonic acids as thickeners in preparations comprising organic solvents | CLARIANT GMBH | 2003-01-02 | — | — | US | disclosed |
| EP-1251142-A1 | Use of copolymers based on acrylamidoalkylenesulphonic acid as thickener in compositions containing an organic solvent | Clariant GmbH (DE) | 2002-10-23 | — | — | EP | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |